из города:
San Antonio
день рождения:
|
Docetaxel (as generic or under the trade eminence Taxotere) is a clinically traditional anti-mitotic chemotherapy medication (medication which interferes with cubicle division). It is used in general exchange for the treatment of mamma, ovarian, prostate, and non-small chamber lung cancer.[1][2][3] Docetaxel has an FDA approved call for after treatment of patients who partake of locally advanced, or metastatic heart of hearts or non small-cell lung cancer who procure undergone anthracycline-based chemotherapy and failed to hold back cancer advance or relapsed[4] and a European imprimatur instead of use in hormone-refractory prostate cancer.[5]
According to a 2005 article in the journal Drugs, docetaxel administered as a one-hour infusion every three weeks generally in excess of a ten rotate dispatch, docetaxel is considered as or more compelling than doxorubicin, paclitaxel and fluorouracil as a cytotoxic agent.[1] Respect the effectiveness of docetaxel versus paclitaxel and other taxanes is still controversial. A variety of more brand-new articles be suffering with found "no confirmation that regimens containing docetaxel throw in the towel greater benefits than those including paclitaxel."[6] Additionally, the optimal scheduling of docetaxel and other taxanes remains unconfirmed. A three-week dispensation schedule used to be and is stationary considered efficient but chic studies are indicating a weekly outline effect be better. A 2010 article in Current Clinical Pharmacology states, "weekly application has emerged as the optimal schedule." Docetaxel is marketed worldwide subordinate to the honour Taxotere by Sanofi-Aventis.[7] Annual sales in 2010 were Euro 2.122 billion ($US 3.1 billion). The franchise expired in 2010.[citation
Stamp
Docetaxel is of the chemotherapy pharmaceutical class; taxane, and is a semi-synthetic analogue of paclitaxel (Taxol), an distillate from the bark of the rare Pacific yew tree Taxus brevifolia.[2] Apt to paucity of paclitaxel, international study was carried visible primary to the formulation of docetaxel – an esterified yield of 10-deacetyl baccatin III, which is extracted from the renewable and readily available European yew tree.
Docetaxel differs from paclitaxel at two positions in its chemical structure. It has a hydroxyl useful dispose on carbon 10, whereas paclitaxel has an acetate ester, and a tert-butyl carbamate ester exists on the phenylpropionate side chain as an alternative of the benzyl amide in paclitaxel. The carbon 10 functioning organize change causes docetaxel to be more bath-water soluble than paclitaxel.[2]
Formulations and compositions
Docetaxel is a pale-complexioned right and is the working ingredient at one's disposal in 20 mg and 80 mg Taxotere single-dose vials of concentrated anhydrous docetaxel in polysorbate 80.[2][8] The mixing is a discerning brown-yellow containing 40 mg docetaxel and 1040 mg polysorbate 80 per mL.[8] 20 mg Taxotere is distributed in a blister carton containing chestnut single-dose vial of Taxotere (docetaxel) preparation in 0.5 mL infecund pyrogen-free anhydrous polysorbate 80, and a single portion Taxotere creditworthy vial containing 1.5 mL 13% ethanol in saline to be combined and diluted in a 250 mL infusion case containing 0.9% sodium chloride or 5% glucose for administration.[8] 80 mg Taxotere is supplied identically but with 2.0 mL polysorbate 80 and 6.0 mL 13% ethanol in saline. The docetaxel and profitable vials are combined to give a unravelling of 10 mg/mL and the required dose is exhausted from this solution. Vials suffer with an overfill to indemnify in compensation solvent set-back during preparation, foaming, adhesion to vial walls and the uninteresting volume. 20 mg vials may be stored in the service of 24 months below 25 °C away from understanding and 80 mg vials for 26 months in the yet conditions.[8]
Recently Sanofi has got authorization for one-vial formulation.[citation needed] With this one-vial formulation, the preparation of the infusion answer is simplified during eliminating the before dilution step. The two-vial and one-vial formulations restrict the unchanged panacea point, docetaxel trihydrate, and the same excipients (ethanol, polysorbate 80 and citric acid). The one-vial formulation is administered as an aqueous intravenous resolution that contains the done drug theme in the after all is said concentration as the already approved two-vial formulation. The in spite of grade, status, and quantity of polysorbate 80 are put on show in the infusion solution of both formulations. The only argument between these two formulations is the volume of ethanol.
From [url=http://www.tcsindustry.com]TCS INDUSTRY LTD[/url] |
